GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC10451 structure
    GC10451U-73122
    CAS: 112648-68-7
    Purity: >98.00%

    U-73122은 IC50 값이 약 1-2.1μM인 강력하고 선택적인 인지질효소 C(PLC) 억제제이다. 게다가 5-lipoxygenase (5-LO) 을 억제한다.

  • GC10692 structure
    GC10692Caffeic Acid Phenethyl Ester
    CAS: 104594-70-9
    Purity: >98.00%

    Caffeic Acid Phenethyl Ester는 프로폴리스에 자연적으로 존재하는 페닐프로파노이드 화합물로 다양한 생물학적 활성을 지닌다.

  • GC10712 structure
    GC10712Imiquimod hydrochloride
    CAS: 99011-78-6
    Purity: >99.50%

    면역 반응 조절제인 이미퀴모드 히드로클로라이드(R 837 히드로클로라이드)는 수용체 7(TLR7) 작용제와 같은 선택적 톨입니다.

  • GC10933 structure
    GC10933Sodium 4-Aminosalicylate
    CAS: 6018-19-5
    Purity: >99.50%

    Sodium 4-Aminosalicylate(4-Aminosalicylic acid sodium salt dihydrate)는 현재 다제내성결핵에 사용되는 항진균제 중 하나입니다.

  • GC11438 structure
    GC11438JSH-23
    CAS: 749886-87-1
    Purity: >98.00%

    JSH-23은 lipopolysaccharide (LPS)가 자극한 RAW 264.7 매크로파지에서 핵 이동과 NF-κB 전사활동에 대한 억제 효과를 보여주며, 그 IC50 값은 7.1 μM이다.

  • GC11719 structure
    GC11719HG-9-91-01
    CAS: 1456858-58-4
    Purity: >99.00%

    HG-9-91-01은 salt-inducible kinases (SIK) 억제제로, SIK1, SIK2, SIK3를 각각 0.92nM, 6.5nM, 19.4nM의 IC50 값으로 억제한다.

  • GC11819 structure
    GC11819Strontium Ranelate
    CAS: 135459-87-9
    Purity: >99.50%

    스트론튬 라넬레이트(S12911)는 골흡수를 감소시키고 골형성을 촉진하는 작용을 하여 긍정적인 골밸런스를 유도하는 항골다공성 제제입니다.

  • GC12013 structure
    GC12013Sodium salicylate
    CAS: 54-21-7
    Purity: >99.50%

    Sodium Salicylate(Salicylic acid sodium salt)는 전사인자(NF-κB) 활성화와 무관하게 cyclo-oxygenase-2(COX-2) 활성을 억제합니다.

  • GC12180 structure
    GC12180IKK-16 (IKK Inhibitor VII)
    CAS: 873225-46-8
    Purity: >99.00%

    IKK-16 (IKK Inhibitor VII)은 신형 경구활성 선택적 IκB 키나아제(IKK)억제제로 IKK-2, IKK 복합체 및 IKK-1에 대한 IC₅₀ 값은 각각 40nM, 70nM 및 200nM이다.

  • GC12645 structure
    GC12645Imiquimod maleate
    CAS: 896106-16-4
    Purity: >98.00%

    면역 반응 조절제인 이미퀴모드 말레에이트(R 837 말레에이트)는 수용체 7(TLR7) 작용제와 같은 선택적 톨입니다.

  • GC13066 structure
    GC13066Y-320
    CAS: 288250-47-5
    Purity: >99.00%

    Y-320은 강력한 경구 활성 페닐피라졸아닐리드 면역조절제입니다.

  • GC13650 structure
    GC13650Resiquimod (R-848)
    CAS: 144875-48-9
    Purity: >99.50%

    Resiquimod (R-848)은 잠재적인 항바이러스 활성을 가지고 있는 이미다조퀴놀린 합성물질이다.

  • GC14352 structure
    GC14352TAT 14
    CAS: 1362661-34-4
    Purity: >98.00%

    TAT 14는 항염증 효과가 있는 Nrf2 활성제로 작용하는 14-mer 펩타이드입니다.

  • GC14435 structure
    GC14435Zileuton sodium
    CAS: 118569-21-4
    Purity: >98%

    질류톤 나트륨(A 64077 나트륨)은 5-리폭시게나제의 강력하고 선택적인 억제제로 염증 활성을 나타냅니다.

  • GC14438 structure
    GC14438Suprofen
    CAS: 40828-46-4
    Purity: >99.50%

    Suprofen(TN-762)은 비스테로이드성 항염증제(NSAID)입니다.

  • GC14633 structure
    GC14633HPGDS inhibitor 1
    CAS: 1033836-12-2
    Purity: >99.00%

    HPGDS 억제제 1은 효소 및 세포 분석에서 각각 IC50이 0.6nM 및 32nM인 강력한 선택적 경구 활성 조혈 프로스타글란딘 D 합성효소(HPGDS) 억제제입니다.

  • GC14751 structure
    GC14751Malotilate
    CAS: 59937-28-9
    Purity: >99.50%

    말로틸레이트(NKK 105), 경구 활성 간기능 강화제 및 항섬유화 물질은 5-리폭시게나제(5-LOX)(IC50=4.7μM)를 선택적으로 억제합니다. Malotilate는 간의 아세트알데히드 수치를 감소시키고 간세포에서 트랜스페린의 체류를 방지함으로써 알코올-피라졸 간염에서 간세포 손상의 발병을 예방합니다.

  • GC16014 structure
    GC16014Zileuton
    CAS: 111406-87-2
    Purity: >99.00%

    Zileuton은 벤조티오펜 N-하이드록시우레아이고 구강용 5-리포옥시젠레이스 억제제이다.

  • GC16120 structure
    GC16120AI-3
    CAS: 882288-28-0
    Purity: >98%

    Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor

  • GC16148 structure
    GC16148TAK-242
    CAS: 243984-11-4
    Purity: >98.00%

    TAK-242는 톨류 수용체 4(TLR4) 신호 억제제로 NO, TNF-α 및 IL-6 생성에 대한 IC₅₀ 값은 각각 1.8nM, 1.9nM 및 1.3nM이다.

  • GC16590 structure
    GC16590Dimethyl Fumarate
    CAS: 624-49-7
    Purity: >97.00%

    Dimethyl fumarate(DMF)는 경구 활성 및 뇌 침투성 Nrf2 활성화제이며 항산화 유전자 발현의 상향 조절을 유도합니다.

  • GC16607 structure
    GC16607Mesalamine
    CAS: 89-57-6
    Purity: >98.00%

    5-아미노살리실산(메살라민)은 특정 PPARγ로 작용합니다. 작용제 및 또한 p21 활성화 키나제 1(PAK1) 및 NF-κ를 억제합니다. B.

  • GC16641 structure
    GC16641ML130 (Nodinitib-1)
    CAS: 799264-47-4
    Purity: >99.50%

    ML130(Nodinitib-1)(ML130;CID-1088438)은 IC50이 0.56 μ인 NOD1 억제제입니다.

  • GC16880 structure
    GC16880Flurbiprofen
    CAS: 5104-49-4
    Purity: >99.50%

    Flurbiprofen(dl-Flurbiprofen)은 해열 및 진통 활성이 있는 강력한 경구 활성 비스테로이드성 항염증제(NSAIA/NSAID)입니다.